Cardiology

Ischemic outcomes don't vary with gender in ACS patients

(HealthDay)—For acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) and receiving clopidogrel, prasugrel, or ticagrelor, ischemic outcome does not differ by gender, according to a ...

Cardiology

Vitamin K antagonist plus clopidogrel feasible for PCI

(HealthDay)—Vitamin K antagonists (VKA) combined with clopidogrel may be a better alternative to triple anticoagulant therapy in patients on long-term VKA undergoing percutaneous coronary intervention (PCI) and stenting, ...

page 2 from 11